BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31243343)

  • 1. REGγ ablation impedes dedifferentiation of anaplastic thyroid carcinoma and accentuates radio-therapeutic response by regulating the Smad7-TGF-β pathway.
    Jiao C; Li L; Zhang P; Zhang L; Li K; Fang R; Yuan L; Shi K; Pan L; Guo Q; Gao X; Chen G; Xu S; Wang Q; Zuo D; Wu W; Qiao S; Wang X; Moses R; Xiao J; Li L; Dang Y; Li X
    Cell Death Differ; 2020 Feb; 27(2):497-508. PubMed ID: 31243343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REGγ potentiates TGF-β/Smad signal dependent epithelial-mesenchymal transition in thyroid cancer cells.
    Bhatti MZ; Pan L; Wang T; Shi P; Li L
    Cell Signal; 2019 Dec; 64():109412. PubMed ID: 31491459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
    Hao F; Zhu Q; Lu L; Sun S; Huang Y; Zhang J; Liu Z; Miao Y; Jiao X; Chen D
    Oncol Res; 2020 Sep; 28(4):345-355. PubMed ID: 32138807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer.
    Tang J; Tian Z; Liao X; Wu G
    Int J Biol Sci; 2021; 17(2):417-429. PubMed ID: 33613102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capsaicin restores sodium iodine symporter-mediated radioiodine uptake through bypassing canonical TSH‒TSHR pathway in anaplastic thyroid carcinoma cells.
    Xu S; Cheng X; Wu J; Wang Y; Wang X; Wu L; Yu H; Bao J; Zhang L
    J Mol Cell Biol; 2022 Jan; 13(11):791-807. PubMed ID: 34751390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of the REGγ-proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells.
    Ali A; Wang Z; Fu J; Ji L; Liu J; Li L; Wang H; Chen J; Caulin C; Myers JN; Zhang P; Xiao J; Zhang B; Li X
    Nat Commun; 2013; 4():2667. PubMed ID: 24157709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK Inhibition Induces Therapeutic Iodine Uptake in a Murine Model of Anaplastic Thyroid Cancer.
    ElMokh O; Taelman V; Radojewski P; Roelli MA; Stoss A; Dumont RA; Dettmer MS; Phillips WA; Walter MA; Charles RP
    J Nucl Med; 2019 Jul; 60(7):917-923. PubMed ID: 30464041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid Follicular Cell Loss of Differentiation Induced by MicroRNA miR-17-92 Cluster Is Attenuated by CRISPR/Cas9n Gene Silencing in Anaplastic Thyroid Cancer.
    Fuziwara CS; Saito KC; Kimura ET
    Thyroid; 2020 Jan; 30(1):81-94. PubMed ID: 31578932
    [No Abstract]   [Full Text] [Related]  

  • 9. Proteasome-dependent degradation of Smad7 is critical for lung cancer metastasis.
    Tong L; Shen S; Huang Q; Fu J; Wang T; Pan L; Zhang P; Chen G; Huang T; Li K; Liu Q; Xie S; Yang X; Moses RE; Li X; Li L
    Cell Death Differ; 2020 Jun; 27(6):1795-1806. PubMed ID: 31767934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer.
    Oh JM; Baek SH; Gangadaran P; Hong CM; Rajendran RL; Lee HW; Zhu L; Gopal A; Kalimuthu S; Jeong SY; Lee SW; Lee J; Ahn BC
    Thyroid; 2020 Apr; 30(4):501-518. PubMed ID: 31928162
    [No Abstract]   [Full Text] [Related]  

  • 11. Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer.
    Pan Z; Lu X; Xu T; Chen J; Bao L; Li Y; Gong Y; Che Y; Zou X; Tan Z; Huang P; Ge M
    Cancer Lett; 2024 Jan; 580():216496. PubMed ID: 37993084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer.
    Tesselaar MH; Crezee T; Schuurmans I; Gerrits D; Nagarajah J; Boerman OC; van Engen-van Grunsven I; Smit JWA; Netea-Maier RT; Plantinga TS
    J Nucl Med; 2018 May; 59(5):780-786. PubMed ID: 29242405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.
    Pan Z; Fang Q; Li L; Zhang Y; Xu T; Liu Y; Zheng X; Tan Z; Huang P; Ge M
    Cancer Lett; 2021 Mar; 501():31-42. PubMed ID: 33359451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
    Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
    Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells.
    Wu J; Li YT; Tian XT; Liu YS; Wu ML; Li PN; Liu J
    Cancer Biomark; 2020; 27(4):461-469. PubMed ID: 31958078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse Agonist of Estrogen-Related Receptor γ Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer Cells.
    Singh TD; Jeong SY; Lee SW; Ha JH; Lee IK; Kim SH; Kim J; Cho SJ; Ahn BC; Lee J; Jeon YH
    J Nucl Med; 2015 Nov; 56(11):1690-6. PubMed ID: 26338896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation.
    Liao Y; Hua Y; Li Y; Zhang C; Yu W; Guo P; Zou K; Li W; Sun Y; Wang R; Zuo Y; Sui S; Tian C; Hao J; Chen M; Hu S; Chen M; Long Q; Wang X; Zou L; Xie F; Guo W; Deng W
    Cell Death Differ; 2021 Apr; 28(4):1347-1363. PubMed ID: 33162555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer.
    Antognelli C; Moretti S; Frosini R; Puxeddu E; Sidoni A; Talesa VN
    Cells; 2019 Jun; 8(6):. PubMed ID: 31174324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
    Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
    J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.